Literature DB >> 11251207

Region specific increase of dopamine receptor D1/D2 mRNA expression in the brain of mu-opioid receptor knockout mice.

Y Park1, I K Ho, L W Fan, H H Loh, K H Ko.   

Abstract

Previous pharmacological studies have indicated the possible existence of functional interactions between opioidergic and dopaminergic neurons in the CNS. In this study, the expression of mRNAs encoding dopamine receptor D1/D2 was examined to investigate whether there is a change in the dopamine pathway of mice lacking the mu-opioid receptor by in situ hybridization technique. In the mu-opioid receptor knockout mice, the expression of dopamine receptor D1 mRNA was increased in the olfactory tubercle, nucleus accumbens, caudate putamen, and the layer VI of the neocortex compared with that of wild-type mice. The expression of dopamine receptor D2 mRNA was also increased in the olfactory tubercle, caudate putamen, and the nucleus accumbens of mu-opioid receptor knockout mice. These results indicate that there are compensational changes in the dopaminergic systems of mu-opioid receptor knockout mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251207     DOI: 10.1016/s0006-8993(01)02001-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone.

Authors:  Chi-Tso Chiu; Tangeng Ma; Ing K Ho
Journal:  Brain Res Bull       Date:  2005-09-30       Impact factor: 4.077

2.  Role of mu-opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine-sensitized mice.

Authors:  Lu-Tai Tien; Ing-Kang Ho; Horace H Loh; Tangeng Ma
Journal:  J Neurosci Res       Date:  2007-02-15       Impact factor: 4.164

3.  The differential contribution of dopamine D(1) and D (2) receptors to mu-opioidergic immunomodulation.

Authors:  M A Cheido; G V Idova
Journal:  Neurosci Behav Physiol       Date:  2007-09

4.  Mu Opioid Receptors in Gamma-Aminobutyric Acidergic Forebrain Neurons Moderate Motivation for Heroin and Palatable Food.

Authors:  Pauline Charbogne; Olivier Gardon; Elena Martín-García; Helen L Keyworth; Aya Matsui; Anna E Mechling; Thomas Bienert; Md Taufiq Nasseef; Anne Robé; Luc Moquin; Emmanuel Darcq; Sami Ben Hamida; Patricia Robledo; Audrey Matifas; Katia Befort; Claire Gavériaux-Ruff; Laura-Adela Harsan; Dominik von Elverfeldt; Jurgen Hennig; Alain Gratton; Ian Kitchen; Alexis Bailey; Veronica A Alvarez; Rafael Maldonado; Brigitte L Kieffer
Journal:  Biol Psychiatry       Date:  2016-12-26       Impact factor: 13.382

5.  Changes in acetylcholinesterase activity and muscarinic receptor bindings in mu-opioid receptor knockout mice.

Authors:  Lu-Tai Tien; Lir-Wan Fan; Chiharu Sogawa; Tangeng Ma; Horance H Loh; Ing-Kang Ho
Journal:  Brain Res Mol Brain Res       Date:  2004-07-05

6.  Unaltered D1, D2, D4, and D5 dopamine receptor mRNA expression and distribution in the spinal cord of the D3 receptor knockout mouse.

Authors:  Hong Zhu; Stefan Clemens; Michael Sawchuk; Shawn Hochman
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2008-09-17       Impact factor: 1.836

7.  Autoradiographic analysis of GABAA receptors in mu-opioid receptor knockout mice.

Authors:  Lu-Tai Tien; Tangeng Ma; Lir-Wan Fan; Horace H Loh; Ing-Kang Ho
Journal:  Neurochem Res       Date:  2007-06-12       Impact factor: 3.996

8.  Autoantibodies against opioid or glutamate receptors are associated with changes in morphine reward and physical dependence in mice.

Authors:  Francesca Capone; Walter Adriani; Maria Shumilina; Galina Izykenova; Oleg Granstrem; Svetlana Dambinova; Giovanni Laviola
Journal:  Psychopharmacology (Berl)       Date:  2008-02-12       Impact factor: 4.530

Review 9.  Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics.

Authors:  Piotr F J Lipiński; Joanna Matalińska
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.